resaearch

Study launched to better understand real-world impact and progression of COPD

April 07, 2017

Duke Clinical Research Institute, Duke University’s MURDOCK Study and Boehringer Ingelheim Pharmaceuticals Launch Innovative Clinical Research Study KANNAPOLIS, N.C. and RIDGEFIELD, Conn.—April 7, 2017—Duke University’s MURDOCK Study, the Duke Clinical Research Institute (DCRI) and Boehringer Ingelheim Pharmaceuticals Inc. announced today the launch of a new collaborative research effort to closely follow 850 people living with […]